These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute generalized exanthematous pustulosis induced by gliclazide: a case report. Contreras-Steyls M; Vílchez-Márquez F; Mota A; Moyano B; Herrera-Ceballos E Int J Dermatol; 2013 Dec; 52(12):1591-3. PubMed ID: 24261739 [No Abstract] [Full Text] [Related]
7. Eosinophilic pleural effusion due to gliclazide. Tzanakis N; Bouros D; Siafakas N Respir Med; 2000 Jan; 94(1):94. PubMed ID: 10714487 [No Abstract] [Full Text] [Related]
8. Is gliclazide a new antidiabetic drug implicated in the pathogenesis of ocular mucous membrane pemphigoid? Cozzani E; Di Zenzo G; Cioni M; Javor S; Altieri M; Anselmi L; Parodi A Eur J Dermatol; 2018 Jun; 28(3):396-397. PubMed ID: 29547128 [No Abstract] [Full Text] [Related]
9. Erythroderma secondary to gliclazide: a case report. Ozuguz P; Kacar SD; Ozuguz U; Karaca S; Tokyol C Cutan Ocul Toxicol; 2014 Dec; 33(4):342-4. PubMed ID: 24641117 [TBL] [Abstract][Full Text] [Related]
10. Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide. Lee JY; Kim G; Lee YH; Lee BW; Cha BS; Nam CM; Kang ES Diabetes Metab; 2019 Jan; 45(1):83-85. PubMed ID: 28778564 [No Abstract] [Full Text] [Related]
17. [Rhabdomyolysis induced by fenofibrate monotherapy]. Archambeaud-Mouveroux F; Lopez S; Combes C; Lassandre S; Amaniou M; Teissier MP; Galinat S Rev Med Interne; 2006 Jul; 27(7):573-4. PubMed ID: 16716459 [TBL] [Abstract][Full Text] [Related]
18. [Recurrent toxic severe hypoglycemias]. Borel M; Goullé JP; Lacroix C; Bouige D Ann Biol Clin (Paris); 2001; 59(6):751-4. PubMed ID: 11713020 [No Abstract] [Full Text] [Related]
19. Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes. Braatvedt GD N Z Med J; 1997 May; 110(1044):189-90. PubMed ID: 9201206 [No Abstract] [Full Text] [Related]
20. Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes. Vilar L; Canadas V; Arruda MJ; Arahata C; Agra R; Pontes L; Montenegro L; Vilar CF; Silva LM; Albuquerque JL; Gusmão A Arq Bras Endocrinol Metabol; 2010 Mar; 54(3):311-8. PubMed ID: 20520962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]